Sun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking Susmita Roy11 Dec 2025 4:08 PM ISTNew Delhi: The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide...
Semaglutide Patent War: After Dr Reddy's Blow, Novo Nordisk Moves Delhi HC Against Sun Pharma Susmita Roy9 Dec 2025 5:00 PM ISTNew Delhi: In an escalation of India's unfolding GLP-1 patent war, Novo Nordisk has approached the Delhi High Court to restrain Sun Pharmaceutical...
New fat-burning diabetes pill protects muscle and appetite, reports research Dr. Kamal Kant Kohli8 Dec 2025 8:00 PM ISTLowering blood sugar and increasing fat burning without reducing appetite or muscle mass is emerging as a promising possibility in the treatment of...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Tradipitant may Reduce Semaglutide-Induced Nausea and Vomiting, reports research Dr. Kamal Kant Kohli21 Nov 2025 8:00 PM ISTIn a randomized trial of adults with obesity or overweight, Vanda Pharmaceuticals' investigational NK-1 receptor antagonist tradipitant significantly...
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India's Top-Selling Drug Farhat Nasim8 Nov 2025 5:06 PM ISTNew Delhi: Eli Lilly's diabetes and obesity drug Mounjaro (Tirzepatide) has become India's top-selling drug by value for October 2025, overtaking...
Medical Bulletin 28/October/2025 Anshika Mishra28 Oct 2025 3:00 PM ISTHere are the top medical news for the day:Study explores health risks of ultra-processed plant foods vs meat An in-depth narrative review in Current...
Weight-loss drugs like Ozempic may help reduce drug and alcohol addiction risks: Study Anshika Mishra28 Oct 2025 8:15 AM ISTResearchers have identified Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs)—medications already used for diabetes and obesity—as promising...
Weight-loss drugs may also curb drug and alcohol addiction, finds study Dr. Kamal Kant Kohli27 Oct 2025 9:00 PM ISTA promising group of medications already used to treat diabetes and obesity may also hold potential for tackling alcohol and drug addiction, according...
From Breakthrough to Backlash: Novo Nordisk's Ozempic Faces USD 2 Billion Lawsuit Farhat Nasim22 Aug 2025 6:32 PM ISTNew Delhi: Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated as a...
Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli Lilly Farhat Nasim15 Aug 2025 3:14 PM ISTJohannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and...
Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report Farhat Nasim29 July 2025 10:09 PM ISTNew Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...
